Also, the clinical significance of p17/PERMIT‐CerS1‐C18‐ceramide‐mediated mitophagy alterations in the development and progression of ALS or other aging‐dependent sensorimotor deficiencies must be determined in a larger cohort of patients. The gene discussed is CERS1; the disease is amyotrophic lateral sclerosis.